Bacterial pneumonia risk factors: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 29: Line 29:
*African Americans<ref name="pmid30020693">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume=  | issue=  | pages=  | pmid=30020693 | doi= | pmc= | url= }} </ref>
*African Americans<ref name="pmid30020693">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume=  | issue=  | pages=  | pmid=30020693 | doi= | pmc= | url= }} </ref>


==== Pneumonia in relation to other Drugs/ Other medications used: ====
====Pneumonia in relation to other Drugs/ Other medications used:====


* Atypical antipsychotics have been shown to ''increase'' the risk of pneumonia, especially in elderly individuals. <ref name="pmid18266664">{{cite journal| author=Knol W, van Marum RJ, Jansen PA, Souverein PC, Schobben AF, Egberts AC| title=Antipsychotic drug use and risk of pneumonia in elderly people. | journal=J Am Geriatr Soc | year= 2008 | volume= 56 | issue= 4 | pages= 661-6 | pmid=18266664 | doi=10.1111/j.1532-5415.2007.01625.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18266664  }} </ref>
*Atypical antipsychotics have been shown to ''increase'' the risk of pneumonia, especially in elderly individuals. <ref name="pmid18266664">{{cite journal| author=Knol W, van Marum RJ, Jansen PA, Souverein PC, Schobben AF, Egberts AC| title=Antipsychotic drug use and risk of pneumonia in elderly people. | journal=J Am Geriatr Soc | year= 2008 | volume= 56 | issue= 4 | pages= 661-6 | pmid=18266664 | doi=10.1111/j.1532-5415.2007.01625.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18266664  }} </ref>
* Use of Acid Suppressing drugs ( [[H2 blocker|H2 blockers]], [[Proton pump inhibitor|proton pump inhibitors]], and other [[Antacid|antacids]]) may ''increase'' the risk of pneumonia.<ref name="pmid15507580">{{cite journal| author=Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB| title=Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. | journal=JAMA | year= 2004 | volume= 292 | issue= 16 | pages= 1955-60 | pmid=15507580 | doi=10.1001/jama.292.16.1955 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15507580  }} </ref>  
*Use of Acid Suppressing drugs ([[H2 blocker|H2 blockers]], [[Proton pump inhibitor|proton pump inhibitors]], and other [[Antacid|antacids]]) may ''increase'' the risk of pneumonia.<ref name="pmid15507580">{{cite journal| author=Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB| title=Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. | journal=JAMA | year= 2004 | volume= 292 | issue= 16 | pages= 1955-60 | pmid=15507580 | doi=10.1001/jama.292.16.1955 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15507580  }} </ref>
* ACE inhibitors may be helpful in ''reducing'' the risk of pneumonia.<ref name="pmid22786934">{{cite journal| author=Caldeira D, Alarcão J, Vaz-Carneiro A, Costa J| title=Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis. | journal=BMJ | year= 2012 | volume= 345 | issue=  | pages= e4260 | pmid=22786934 | doi=10.1136/bmj.e4260 | pmc=3394697 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22786934  }}  [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=23165678 Review in: Ann Intern Med. 2012 Nov 20;157(10):JC5-2] </ref>
*ACE inhibitors may be helpful in ''reducing'' the risk of pneumonia.<ref name="pmid22786934">{{cite journal| author=Caldeira D, Alarcão J, Vaz-Carneiro A, Costa J| title=Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis. | journal=BMJ | year= 2012 | volume= 345 | issue=  | pages= e4260 | pmid=22786934 | doi=10.1136/bmj.e4260 | pmc=3394697 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22786934  }}  [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=23165678 Review in: Ann Intern Med. 2012 Nov 20;157(10):JC5-2] </ref>


==References==
==References==

Revision as of 06:09, 2 January 2022

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Arooj Naz

Overview

Bacterial pneumonia can affect individuals any age, gender, or race and has minimal significance in relation to family history although those with underlying immunoglobulin defects have a higher likelihood of infection. It tends to affect men more often than women, and is more common in African Americans compared to Caucasians. Socioeconomic status is an important contributing factors and may explain the increased prevalence rate in low to middle income nations.[1]


Pneumonia Main Page

Bacterial pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Bacterial pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bacterial pneumonia risk factors On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bacterial pneumonia risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bacterial pneumonia risk factors

CDC onBacterial pneumonia risk factors

Bacterial pneumonia risk factors in the news

Blogs on Bacterial pneumonia risk factors

to Hospitals Treating Bacterial pneumonia

Risk calculators and risk factors for Bacterial pneumonia risk factors

Risk Factors

Common risk factors in the development of bacterial pneumonia include:

Pneumonia in relation to other Drugs/ Other medications used:

  • Atypical antipsychotics have been shown to increase the risk of pneumonia, especially in elderly individuals. [8]
  • Use of Acid Suppressing drugs (H2 blockers, proton pump inhibitors, and other antacids) may increase the risk of pneumonia.[9]
  • ACE inhibitors may be helpful in reducing the risk of pneumonia.[10]

References

  1. ↑ 1.0 1.1 Roomaney RA, Pillay-van Wyk V, Awotiwon OF, Dhansay A, Groenewald P, Joubert JD; et al. (2016). "Epidemiology of lower respiratory infection and pneumonia in South Africa (1997-2015): a systematic review protocol". BMJ Open. 6 (9): e012154. doi:10.1136/bmjopen-2016-012154. PMC 5030548. PMID 27633638.
  2. ↑ 2.0 2.1 2.2 "StatPearls". 2021. PMID 28613500.
  3. ↑ Alshahwan SI, Alsowailmi G, Alsahli A, Alotaibi A, Alshaikh M, Almajed M; et al. (2019). "The prevalence of complications of pneumonia among adults admitted to a tertiary care center in Riyadh from 2010-2017". Ann Saudi Med. 39 (1): 29–36. doi:10.5144/0256-4947.2019.29. PMC 6464674. PMID 30712048.
  4. ↑ Schussler E, Beasley MB, Maglione PJ (2016). "Lung Disease in Primary Antibody Deficiencies". J Allergy Clin Immunol Pract. 4 (6): 1039–1052. doi:10.1016/j.jaip.2016.08.005. PMC 5129846. PMID 27836055.
  5. ↑ Baskaran V, Murray RL, Hunter A, Lim WS, McKeever TM (2019). "Effect of tobacco smoking on the risk of developing community acquired pneumonia: A systematic review and meta-analysis". PLoS One. 14 (7): e0220204. doi:10.1371/journal.pone.0220204. PMC 6638981 Check |pmc= value (help). PMID 31318967.
  6. ↑ Prasso JE, Deng JC (2017). "Postviral Complications: Bacterial Pneumonia". Clin Chest Med. 38 (1): 127–138. doi:10.1016/j.ccm.2016.11.006. PMC 5324726. PMID 28159155.
  7. ↑ 7.0 7.1 "StatPearls". 2021. PMID 30020693.
  8. ↑ Knol W, van Marum RJ, Jansen PA, Souverein PC, Schobben AF, Egberts AC (2008). "Antipsychotic drug use and risk of pneumonia in elderly people". J Am Geriatr Soc. 56 (4): 661–6. doi:10.1111/j.1532-5415.2007.01625.x. PMID 18266664.
  9. ↑ Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB (2004). "Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs". JAMA. 292 (16): 1955–60. doi:10.1001/jama.292.16.1955. PMID 15507580.
  10. ↑ Caldeira D, Alarcão J, Vaz-Carneiro A, Costa J (2012). "Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis". BMJ. 345: e4260. doi:10.1136/bmj.e4260. PMC 3394697. PMID 22786934. Review in: Ann Intern Med. 2012 Nov 20;157(10):JC5-2

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Bacterial_pneumonia_risk_factors&oldid=1717869"